Cheong, Kelby M.Kelby M.Cheong2012-10-202018-07-062012-10-202018-07-062011http://ntur.lib.ntu.edu.tw//handle/246246/243339en-US[SDGs]SDG3oral contraceptive agent; age distribution; comorbidity; criterion variable; disease association; disease classification; follow up; health insurance; human; incidence; letter; medical research; national health insurance; ovary cancer; pelvic inflammatory disease; population research; prevalence; priority journal; risk assessment; Taiwan; women's health; Female; Humans; Ovarian Neoplasms; Pelvic Inflammatory Diseasejournal article10.1016/S1470-2045(11)70351-5http://ntur.lib.ntu.edu.tw/bitstream/246246/243339/-1/37.pdf